Original Research and the Latest News
Recent Posts
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency
Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team...
Covid-19 Clinical Trials and Where to Get Treated
We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another,...
Case Study Market Scan – Understanding the Competition and Defining Opportunity
A small startup medical device company needed a broader understanding of its potential competitors and a more complete picture...
Pharma Forecasting Case Study – Valuing the Impact of Development Delays
A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new...
PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team...
ELI LILLY in the Diabetes Market
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human...
Pharma Forecasting Case Study – Shaping R&D Strategy
The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a...
Forecasting – Applying Pharmaceutical Valuation Approach in the Foster Care Setting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding...
Case Study Market Scan – Surveying Pharmaceutical Markets in Asia Pacific
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy...
A Gift for Patients – Medicare to Cover Lung Cancer Screening
LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by...
Building a Case Study Portfolio Framework
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio,...
We’re Back!
Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have...
Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April
The Annual Meeting of the American Association for Cancer Research (AACR) is taking place April 5-10 in San Diego. AACR...
7 Small-Cap Biotech Companies to Watch at AACR in April
We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the...
How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%
Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success...
Market Overview: GLP-1 Agonists and the Obesity Market
Introduction to GLP-1 AgonistsGLP-1 agonists have been pivotal in the pharmaceutical market for nearly two decades, beginning...
Clinical Trial Success Rates: What Makes Some Companies Stand Out?
Our comprehensive analysis of over 30,000 clinical trials across more than 4,000 biopharmaceutical companies reveals significant...
Not Your Grandparents’ Probability of Success Forecasts
Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and...
Recent Tweets
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762